# BIO-TECHNE Corp (TECH) FY2026 Annual Balance Sheet

- Company: BIO-TECHNE Corp (TECH)
- Period: As of 2026-06-30
- Filing: FY2026 10-K, filed 2026-08-24, accession number 0001104659-26-100322
- Page: https://plicit.ai/financials/tech/fy2026-annual-balance-sheet
- Chart image: https://plicit.ai/charts/tech-fy2026-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,586,726,000 US dollars
- **Current assets**: 744,401,000 US dollars
- **Non-current assets**: 1,842,325,000 US dollars
- **Liabilities (calculated)**: 478,505,000 US dollars
- **Current liabilities**: 163,700,000 US dollars
- **Non-current liabilities**: 314,805,000 US dollars
- **Equity**: 2,108,221,000 US dollars
- **Cash and cash equivalents**: 264,712,000 US dollars
- **Accounts receivable, less allowances of $4,644 and $4,215, respectively**: 216,585,000 US dollars
- **Inventories**: 195,744,000 US dollars
- **Other current assets**: 67,360,000 US dollars
- **Goodwill**: 975,355,000 US dollars
- **Intangible assets, net**: 303,465,000 US dollars
- **Other assets**: 264,336,000 US dollars
- **Property and equipment, net**: 231,836,000 US dollars
- **Right-of-use assets**: 67,333,000 US dollars
- **Salaries, wages and related accruals**: 57,918,000 US dollars
- **Contract liabilities**: 36,072,000 US dollars
- **Trade accounts payable**: 26,699,000 US dollars
- **Accrued expenses**: 20,458,000 US dollars
- **Operating lease liabilities - current**: 14,935,000 US dollars
- **Other current liabilities**: 4,025,000 US dollars
- **Income taxes payable**: 3,593,000 US dollars
- **Long-term debt obligations**: 200,000,000 US dollars
- **Operating lease liabilities**: 74,152,000 US dollars
- **Other long-term liabilities**: 21,345,000 US dollars
- **Deferred income taxes**: 19,308,000 US dollars
- **Retained earnings**: 1,144,188,000 US dollars
- **Additional paid-in capital**: 1,033,052,000 US dollars
- **Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 156,095,113 and 154,972,196 respectively**: 1,561,000 US dollars
- **Undesignated capital stock, par value $.01 per share; authorized 5,000,000 shares; none issued or outstanding**: 0 US dollars
- **Accumulated other comprehensive loss**: negative 70,580,000 US dollars
- **Gross equity (calculated)**: 2,178,801,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.